Edwards Lifesciences Corporation
EW
Xếp hạng trong cổ phiếu
#489
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Giá cổ phiếu
$86.46
Đồng bộ lần cuối: 2026-10-16
Vốn hóa thị trường
$49.82B
Thay đổi (1 ngày)
-1.75%
Thay đổi (1 năm)
15.84%
Quốc gia
US
Giao dịch Edwards Lifesciences Corporation (EW)
Danh mục
Healthcare
EPS của Edwards Lifesciences Corporation (EW)
EPS tính đến June 2026 TTM: $1.74
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Edwards Lifesciences Corporation, EPS hiện tại của công ty (TTM) là $1.74. Vào cuối năm 2024, công ty có EPS là $6.98, tăng so với EPS năm 2023 là $2.31.
Lịch sử EPS của Edwards Lifesciences Corporation từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $1.74 | -5.43% |
| 2025 | $1.84 | -73.64% |
| 2024 | $6.98 | 202.16% |
| 2023 | $2.31 | -6.10% |
| 2022 | $2.46 | 2.07% |
| 2021 | $2.41 | 82.58% |
| 2020 | $1.32 | -21.43% |
| 2019 | $1.68 | 46.09% |
| 2018 | $1.15 | 17.35% |
| 2017 | $0.98 | 10.11% |
| 2016 | $0.89 | 15.58% |
| 2015 | $0.77 | -39.37% |
| 2014 | $1.27 | 115.25% |
| 2013 | $0.59 | 37.21% |
| 2012 | $0.43 | 22.86% |
| 2011 | $0.35 | 9.37% |
| 2010 | $0.32 | -5.88% |
| 2009 | $0.34 | 78.95% |
| 2008 | $0.19 | 18.75% |
| 2007 | $0.16 | -15.79% |
| 2006 | $0.19 | 72.73% |
| 2005 | $0.11 | 4,300.00% |
| 2004 | 0.00 | -97.73% |
| 2003 | $0.11 | 40.49% |
| 2002 | $0.08 | -560.59% |
| 2001 | $-0.02 | -95.64% |
| 2000 | $-0.39 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $3.11 | 78.74% |
US
|
|
| $3.59 | 106.32% |
IE
|
|
| $9.73 | 459.20% |
US
|
|
| $2.48 | 42.53% |
US
|
|
| - | - |
DE
|
